BEIJING ENT (00392.HK): Completes RMB1 Bln Sci-Tech Innovation Corporate Bond Issuance with Coupon Rate of 2.09%

NewTimeSpace · 2026/07/20 17:21 · By Xuran Lin

NewTimeSpace News: BEIJING ENT (00392.HK) announced on 20 July that it has completed the issuance of its Phase 1 publicly offered sci-tech innovation corporate bonds targeted at professional investors. Tranche 1 was not issued, while the 10-year Tranche 2 raised RMB1 billion at a final coupon rate of 2.09%. Issuance results have been disclosed on the SSE official website.

NewTimeSpace News: On 20 July 2026, BEIJING ENT (00392.HK) issued an announcement stating that the Group finished the offering of "2026 Publicly Offered Sci-Tech Innovation Corporate Bonds for Professional Investors (Phase 1)" on the same date.

Tranche 1 of the bond series saw no placement. The 10-year Tranche 2 achieved an actual issuance size of RMB1 billion, with a final fixed coupon rate of 2.09%.

The Company has published the full issuance result notice on the official website of the Shanghai Stock Exchange (SSE). The bonds qualify as sci-tech innovation corporate bonds and are publicly offered solely to professional investors.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.

Tags：

BEIJING ENT 00392.HK Corporate Bond